Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Waked

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The American Journal of Medicine|February 1, 1997
Analysis of long-term endoscopic surveillance during follow-up after variceal sclerotherapy from a 13-year experienceI Waked, J Korula
Drugs of Today (Barcelona, Spain : 1998)|March 17, 2021
Ravidasvir hydrochloride for genotype 1 hepatitis C treatmentA Gomaa, N Allam, I Waked
Clinical and Experimental Dermatology|June 28, 2018
Does transcutaneous electrical nerve stimulation have an antipruritic effect in lichen planus? A randomized clinical trialI Waked, Z Ibrahim, H M I Elgohary
Journal of Viral Hepatitis|November 7, 2017
Estimating HCV disease burden-volume 4 (editorial)G J Dore, A Hatzakis, F Negro, et al.
Scandinavian Journal of Immunology|January 13, 2005
Interleukin (IL)-4, IL-10, IL-18 and IFN-gamma cytokines pattern in patients with combined hepatitis C virus and Schistosoma mansoni infectionsI M El-Kady, M Lotfy, G Badra, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1988
Interferon in chronic active hepatitis B. Preliminary resultsI Waked, M Amin, S A Abd-el Fattah, et al.
Journal of Chemotherapy (Florence, Italy)|October 1, 1990
Experience with interferon in chronic hepatitis B in EgyptI Waked, M Amin, S Abd el Fattah, et al.
Alimentary Pharmacology & Therapeutics|July 24, 2015
Economic burden of hepatitis C in Egypt: the future impact of highly effective therapiesC Estes, M Abdel-Kareem, W Abdel-Razek, et al.
Clinical and Experimental Immunology|September 17, 2020
Association of the polymorphism of the Toll-like receptor (TLR)-3 and TLR-9 genes with hepatitis C virus-specific cell-mediated immunity outcomes among Egyptian health-care workersS F Abdelwahab, S Hamdy, A M Osman, et al.
Journal of Viral Hepatitis|October 30, 2016
Simeprevir plus sofosbuvir for eight or 12 weeks in treatment-naïve and treatment-experienced hepatitis C virus genotype 4 patients with or without cirrhosisM El Raziky, M Gamil, M K Ashour, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The American Journal of Medicine|February 1, 1997
Analysis of long-term endoscopic surveillance during follow-up after variceal sclerotherapy from a 13-year experienceI Waked, J Korula
Drugs of Today (Barcelona, Spain : 1998)|March 17, 2021
Ravidasvir hydrochloride for genotype 1 hepatitis C treatmentA Gomaa, N Allam, I Waked
Clinical and Experimental Dermatology|June 28, 2018
Does transcutaneous electrical nerve stimulation have an antipruritic effect in lichen planus? A randomized clinical trialI Waked, Z Ibrahim, H M I Elgohary
Journal of Viral Hepatitis|November 7, 2017
Estimating HCV disease burden-volume 4 (editorial)G J Dore, A Hatzakis, F Negro, et al.
Scandinavian Journal of Immunology|January 13, 2005
Interleukin (IL)-4, IL-10, IL-18 and IFN-gamma cytokines pattern in patients with combined hepatitis C virus and Schistosoma mansoni infectionsI M El-Kady, M Lotfy, G Badra, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1988
Interferon in chronic active hepatitis B. Preliminary resultsI Waked, M Amin, S A Abd-el Fattah, et al.
Journal of Chemotherapy (Florence, Italy)|October 1, 1990
Experience with interferon in chronic hepatitis B in EgyptI Waked, M Amin, S Abd el Fattah, et al.
Alimentary Pharmacology & Therapeutics|July 24, 2015
Economic burden of hepatitis C in Egypt: the future impact of highly effective therapiesC Estes, M Abdel-Kareem, W Abdel-Razek, et al.
Clinical and Experimental Immunology|September 17, 2020
Association of the polymorphism of the Toll-like receptor (TLR)-3 and TLR-9 genes with hepatitis C virus-specific cell-mediated immunity outcomes among Egyptian health-care workersS F Abdelwahab, S Hamdy, A M Osman, et al.
Journal of Viral Hepatitis|October 30, 2016
Simeprevir plus sofosbuvir for eight or 12 weeks in treatment-naïve and treatment-experienced hepatitis C virus genotype 4 patients with or without cirrhosisM El Raziky, M Gamil, M K Ashour, et al.
Pageof 2